Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Clover Biopharmaceuticals Ltd. ( (HK:2197) ).
Clover Biopharmaceuticals Ltd. announced the results of its Annual General Meeting held on June 19, 2025, where all proposed resolutions were passed unanimously. The meeting also marked the retirement of a non-executive director, and the re-election of other directors, along with the appointment of a new auditor, highlighting the company’s stable governance and strategic planning.
More about Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on developing innovative vaccines and biologic therapeutics, catering to global health needs.
Average Trading Volume: 1,513,917
Technical Sentiment Signal: Hold
Current Market Cap: HK$350.2M
For an in-depth examination of 2197 stock, go to TipRanks’ Overview page.